BridgeMD
New treatment option for Lung Cancer Screening
Official title Advancing Lung Cancer Screening One Text at a Time
ClinicalTrials.gov ID: NCT07227480
What this study is testing
- What it's testing
- The purpose of this study is to assess the feasibility, acceptability, and preliminary impact of text messaging to promote lung cancer screening.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 80
You may be able to join if
- 50 to 80 years old
- have not completed their annual screening for lung cancer
- have a 20 pack-year smoking history
- currently smoke or have quit within the past 15 years
- speak English and/or Spanish
You likely can't join if
- being up-to-date on their annual lung cancer screening
See the full eligibility criteria
- 50 to 80 years old
- have not completed their annual screening for lung cancer
- have a 20 pack-year smoking history
- currently smoke or have quit within the past 15 years
- speak English and/or Spanish
- have a functioning cellphone number with unlimited text messaging capacity
- be willing to complete a baseline and a follow-up (at Month 3) survey
- being up-to-date on their annual lung cancer screening
The study team makes the final eligibility decision.
Where it's taking place
- Rochester, New York, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rochester, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.